✦ LIBER ✦

Antibiotic treatment for bacterial meningitis caused byListeria monocytogenesin a patient with multiple myeloma

✍ Scribed by Sadaya Matano; Shigehiko Satoh; Yukari Harada; Hajime Nagata; Tatsuho Sugimoto

Publisher: Springer
Year: 2010
Tongue: English
Weight: 207 KB
Volume: 16
Category: Article
ISSN: 1341-321X
DOI: 10.1007/s10156-009-0014-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage treatment for patient with multi

Salvage treatment for patient with multiple myeloma refractory to alkylating agents

✍ Gomez, German A. ;Han, Tin ;Ozer, Howard ;Henderson, Edward S. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

Sixteen patients with multiple myeloma refractory to alkylating agents were treated with vincristine 0.25 mg/m2 i.v. on days 1 to 4 and prednisone 1 gm/m2 on days 1 and 3. Chemotherapy was repeated every 2 weeks. Of 15 evaluable patients, five achieved a partial response and four stable disease. Thr

Pulmonary veno-occlusive disease as a ca

Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation

✍ Pankaj Malhotra; Subhash Varma; Neelam Varma; Rati Ram Sharma; Sanjay Jain; Savi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

Weekly treatment with bortezomib for pat

Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma : A phase 2 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; David R. Spigel; John Barton; Cindy Farley; Marshall Schreed 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

## Abstract ## BACKGROUND. The purpose of the current study was to evaluate the efficacy and toxicity of weekly bortezomib in the treatment of patients with recurrent/refractory multiple myeloma. ## METHODS. A total of 40 patients with multiple myeloma who had received either 1 or 2 previous tre

Bortezomib, thalidomide, dexamethasone i

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

✍ Hyeon-Seok Eom; Yeo-Kyeoung Kim; Joo-Seop Chung; Kihyun Kim; Hyo Jung Kim; Ho Yo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 153 KB

Metabolism of a cholesterol-rich microem

Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease

✍ VaniaT.M. Hungria; MariaC. Latrilha; DeboraG. Rodrigues; SergioP. Bydlowski; Car 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 331 KB